ArticleClinical case reports2018
Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3.
Article in Clinical case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- The challenge of composite graft: the use of fluorescent light energy to improve engraftment.Case reports in plastic surgery & hand surgery · 2024Article
- The Importance of Assessing Burning and Stinging when Managing Rosacea: A Review.Acta dermato-venereologica · 2021Review
- Biophotonic Therapy with Fluorescent Light Energy Decreases Facial Erythema, Improves Signs and Symptoms of Rosacea, and Increases Patient Satisfaction: A Postmarket Study.The Journal of clinical and aesthetic dermatology · 2021Article
- Fluorescent light energy combined with systemic isotretinoin: A 52-week follow-up evaluating efficacy and safety in treatment of moderate-severe acne.Clinical case reports · 2021Article
- Fluorescent light energy modulates healing in skin grafted mouse model.Open medicine (Warsaw, Poland) · 2021Article
- Management of otitis externa with an led-illuminated gel: a randomized controlled clinical trial in dogs.BMC veterinary research · 2020Article
- Biophotonic pretreatment enhances the targeting of senile lentigines with a 694 nm QS-ruby laser.Photodermatology, photoimmunology & photomedicine · 2020Article
- Fluorescent Light Energy (FLE) Acts on Mitochondrial Physiology Improving Wound Healing.Journal of clinical medicine · 2020Article
- Fluorescent light energy: A new therapeutic approach to effectively treating acne conglobata and hidradenitis suppurativa.Clinical case reports · 2019Article
- FLUORESCENT LIGHT ENERGY: The Future for Treating Inflammatory Skin Conditions?The Journal of clinical and aesthetic dermatology · 2019Article
- Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3.Clinical case reports · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kleresca® biophotonic platform utilizing fluorescent light energy effectively decreased the inflammatory and erythematous reaction common in rosacea subtypes 1, 2, and 3. Kleresca® may be considered as a single treatment for rosacea, targeting multiple features, or combined with invasive methods for an enhanced normalizing and healing profile of the skin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.